2022
DOI: 10.1002/anbr.202200130
|View full text |Cite
|
Sign up to set email alerts
|

Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis

Abstract: The highly multidrug‐resistant (MDR) Gram‐negative bacterial pathogen Acinetobacter baumannii is a top global health priority where an effective vaccine can protect susceptible populations and limit resistance acquisition. Outer membrane vesicles (OMVs) shed from Gram‐negative bacteria are enriched with virulence factors and membrane lipids but heterogeneous in size and cargo. Herein, a vaccine platform combining precise and replicable nanoparticle technology with immunogenic A. baumannii OMVs (Ab‐OMVs) is rep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 79 publications
0
1
0
Order By: Relevance
“…[16,[52][53][54][55] This diversity within EVs stems from variances in their biogenesis, leading to classifications into different populations, further subdivided into various subsets. [53][54][55] OMVs, being extracellular nanovesicles released by bacteria, exhibit heterogeneity in size (40-300 nm diameter), [11,[56][57][58][59][60] where the size dictates both the entry into host cells and the protein composition. [61][62][63] In our investigation, we noted that a fraction of orally administered A. muciniphila OMVs evades uptake during the journey from the gut to the brain, escaping uptake by other cell types and ultimately being taken up by microglial cells.…”
Section: Discussionmentioning
confidence: 99%
“…[16,[52][53][54][55] This diversity within EVs stems from variances in their biogenesis, leading to classifications into different populations, further subdivided into various subsets. [53][54][55] OMVs, being extracellular nanovesicles released by bacteria, exhibit heterogeneity in size (40-300 nm diameter), [11,[56][57][58][59][60] where the size dictates both the entry into host cells and the protein composition. [61][62][63] In our investigation, we noted that a fraction of orally administered A. muciniphila OMVs evades uptake during the journey from the gut to the brain, escaping uptake by other cell types and ultimately being taken up by microglial cells.…”
Section: Discussionmentioning
confidence: 99%